Astra's first-quarter device sales up 23%:
This article was originally published in Clinica
Astra (Sweden) has reported medical device sales growth of 23% to SKr 153 million ($21 million) for the first quarter of 1995 (ended March 31st). Overall turnover increased 35% to SKr 8,647 million, with net profits up 59% to SKr 2,236 million.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.